ARCHIVES

NCI Alternative to Fixed Number Of Grants Not Popular At NIH; AACR Considers New Issues Groups

This article is from The Cancer Letter archive.

Vol. 09 No. 28 | July 15, 1983

Download PDF Visit The Full Archive

Related Articles

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Nevins: Duke Administration Did a “Very Good Job” Of Handling The Crisis

April 1, 2011

Obese Men More Likely To Have Aggressive Tumors

February 27, 2004

Clinical Trials Streamlining Moves Forward; NCI Commits To Full Funding For Groups

October 9, 1998